2019 International Congress

Wednesday, September 25, 2019

1:15pm-2:45pm

Comparison of Current DBS Platforms in the United States

L. Surillo, U. Yazdani, S. Chitnis (Dallas, TX, USA)

Non-Pharmacological Interventions  ·  Les Muses Terrace, Level 3

1:15pm-2:45pm

Comparison of Dementia Patients With and Without Parkinson’s Disease Before Dementia-related Psychosis Occurs: An Administrative Claims Data Analysis

A. Shim, B. Skoog, V. Abler, N. Rashid, R. Halpern, E. Koep, M. Frazer (San Diego, CA, USA)

Epidemiology  ·  Les Muses, Level 3

1:15pm-2:45pm

Comparison of high versus low frequency subthalamic stimulation on eye movement

MG. Ghilardi, L. Stock, C. Kruger-Zechlin, Z. Deeb, E. Fonoff, L. Timmermann, J. Waldthaler (Sao Paulo, Brazil)

Surgical Therapy  ·  Les Muses Terrace, Level 3

1:15pm-2:45pm

Comparison of PDE10A and DAT expression as markers of disease burden in early Parkinson’s disease

G. Pagano, H. Wilson, T. Yousaf, F. Niccolini, N. Khan, D. Martino, R. Gunn, E. Rabiner, P. Piccini, T. Foltynie, M. Politis (London, United Kingdom)

Neuroimaging  ·  Les Muses Terrace, Level 3

1:15pm-2:45pm

Comparison of Zonisamide with Non-Levodopa, Anti-Parkinson’s disease Drugs in the Incidence of Parkinson’s Disease-Relevant Symptoms

H. Iwaki, M. Tagawa, K. Iwasaki, K. Kawakami, M. Nomoto (Toon, Japan)

Non-Motor Symptoms  ·  Agora 3 West, Level 3

1:15pm-2:45pm

Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways

JJ. Hu, T. Wang (Wuhan, China)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3

1:15pm-2:45pm

Composite UHDRS shows extensive spatial correlation with grey matter and white matter volume in Huntington’s disease gene carriers

C. Estevez-Fraga, E. Johnson, F. Rodrigues, P. Zeun, A. Durr, D. Langbehn, B. Leavitt, R. Roos, S. Gregory, R. Scahill, G. Rees, S. Tabrizi (London, United Kingdom)

Neuroimaging  ·  Les Muses Terrace, Level 3

1:15pm-2:45pm

Compression Therapy: A Treatment of Rubral Tremor

D. Nacopoulos (Erie, PA, USA)

Non-Pharmacological Interventions  ·  Les Muses Terrace, Level 3

1:15pm-2:45pm

Computerized cognitive test profile of 100 patients with and without Amyloid beta 1-42 burden

F. Waga, I. Liepelt-Scarfone, M. Bentele, W. Maetzler, S. Becker, M. Timmers, L. van Nueten, G. Salvadore, K. Brockmann, M. Hobert, J. Streffer, D. Berg (Titusville, NJ, USA)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3

1:15pm-2:45pm

Connectivity alterations in dopaminergic and cholinergic networks mediate cognitive performance in patients with Parkinson’s disease: a resting-state fMRI study

ER. de Natale, SP. Caminiti, Z. Chappell, T. Yousaf, H. Wilson, M. Politis (London, United Kingdom)

Neuroimaging  ·  Les Muses Terrace, Level 3